0.121
                                            Schlusskurs vom Vortag:
              $0.0951
            Offen:
              $0.0765
            24-Stunden-Volumen:
                5.42M
            Relative Volume:
              5.32
            Marktkapitalisierung:
                $145.85K
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              -93.56%
            1M Leistung:
              -97.71%
            6M Leistung:
                -99.96%
            1J Leistung:
              -100.00%
            Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Firmenname
                  
                      Cero Therapeutics Holdings Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      650-407-2376
                    
                Adresse
                  
                      201 HASKINS WAY, SOUTH SAN FRANCISCO
                    
                Vergleichen Sie CERO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CERO
                            
                             
                        Cero Therapeutics Holdings Inc 
                           | 
                    0.121 | 177.38K | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-23 | Hochstufung | D. Boral Capital | Hold → Buy | 
Cero Therapeutics Holdings Inc Aktie (CERO) Neueste Nachrichten
CERo Therapeutics Holdings Inc. Equity Warrant stock trendline breakdownTrade Performance Summary & Precise Swing Trade Alerts - newser.com
Is CERo Therapeutics Holdings Inc. still worth holding after the dipQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
What recovery options are there for CERo Therapeutics Holdings Inc.July 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Why CERo Therapeutics Holdings Inc. stock is considered a top pick2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Short interest data insights for CERo Therapeutics Holdings Inc. Equity Warrant2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
CERO Downgraded to Hold by Maxim Group | CERO Stock News - GuruFocus
CERO SEC FilingsCERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Why CERo Therapeutics Holdings Inc. Equity Warrant stock remains on buy listsWeekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Is it too late to sell CERo Therapeutics Holdings Inc.July 2025 Highlights & Reliable Breakout Forecasts - newser.com
CERo Therapeutics Announces Listing on OTC Markets - The Manila Times
Evaluating CERo Therapeutics Holdings Inc. with trendline analysisMarket Movement Recap & Community Driven Trade Alerts - newser.com
What Fibonacci levels say about CERo Therapeutics Holdings Inc. reboundMarket Risk Summary & Daily Profit Focused Screening - newser.com
CERo Therapeutics (OTC PINK: CERO) lists on OTC Pink, exploring uplist options - Stock Titan
Why CERo Therapeutics Holdings Inc. stock is popular among millennialsQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com
Can CERo Therapeutics Holdings Inc. hit a new high this monthTrade Exit Report & Fast Exit Strategy with Risk Control - newser.com
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts global investors2025 Price Action Summary & Community Driven Trade Alerts - newser.com
Published on: 2025-11-03 04:57:07 - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock trades before earningsEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Can CERo Therapeutics Holdings Inc. stock weather global recessionWeekly Trade Recap & Verified Momentum Watchlists - newser.com
What momentum shifts mean for CERo Therapeutics Holdings Inc.July 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
Will CERo Therapeutics Holdings Inc. stock recover faster than marketQuarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Applying Elliott Wave Theory to CERo Therapeutics Holdings Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com
Using flow based indicators on CERo Therapeutics Holdings Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock reacts to job market dataEarnings Growth Summary & Entry Point Strategy Guides - newser.com
What machine learning models say about CERo Therapeutics Holdings Inc.2025 Trading Recap & Intraday High Probability Alerts - newser.com
Real time breakdown of CERo Therapeutics Holdings Inc. Equity Warrant stock performance2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
How moving averages guide CERo Therapeutics Holdings Inc. tradingQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Published on: 2025-11-03 00:15:03 - newser.com
Can CERo Therapeutics Holdings Inc. Equity Warrant stock attract ESG capital inflowsBull Run & Real-Time Chart Breakout Alerts - newser.com
Can a trend reversal in CERo Therapeutics Holdings Inc. lead to recoveryJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
Leading vs lagging indicators on CERo Therapeutics Holdings Inc. Equity Warrant performanceTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock attractive for income investorsJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Using RSI to spot recovery in CERo Therapeutics Holdings Inc. Equity Warrant2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Identifying reversal signals in CERo Therapeutics Holdings Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com
Tools to assess CERo Therapeutics Holdings Inc.’s risk profileQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Analyzing recovery setups for CERo Therapeutics Holdings Inc. investorsJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Why CERo Therapeutics Holdings Inc. stock is rated strong buy2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
Can swing trading help recover from CERo Therapeutics Holdings Inc. lossesMarket Activity Report & Entry Point Confirmation Signals - newser.com
Published on: 2025-11-01 06:44:28 - newser.com
Multi asset correlation models including CERo Therapeutics Holdings Inc. Equity WarrantQuarterly Portfolio Report & Consistent Profit Trading Strategies - newser.com
Finanzdaten der Cero Therapeutics Holdings Inc-Aktie (CERO)
        Es liegen keine Finanzdaten für Cero Therapeutics Holdings Inc (CERO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
Cero Therapeutics Holdings Inc-Aktie (CERO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 13 '24  | 
                        Sale  | 
                        0.06  | 
                        2,998,908  | 
                        179,934  | 
                        13,005,169  | 
                    
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 12 '24  | 
                        Sale  | 
                        0.07  | 
                        1,614,541  | 
                        113,018  | 
                        16,004,077  | 
                    
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 11 '24  | 
                        Sale  | 
                        0.08  | 
                        1,343,801  | 
                        107,504  | 
                        17,618,618  | 
                    
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 06 '24  | 
                        Sale  | 
                        0.12  | 
                        1,236,874  | 
                        148,425  | 
                        21,383,909  | 
                    
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 10 '24  | 
                        Sale  | 
                        0.09  | 
                        1,570,947  | 
                        141,385  | 
                        18,962,419  | 
                    
| YK Bioventures Opportunities G | 10% Owner  | 
                        Dec 09 '24  | 
                        Sale  | 
                        0.11  | 
                        850,543  | 
                        93,560  | 
                        20,533,366  | 
                    
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):